H. Mytrang

1.5k total citations · 1 hit paper
14 papers, 963 citations indexed

About

H. Mytrang is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, H. Mytrang has authored 14 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in H. Mytrang's work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (3 papers). H. Mytrang is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (3 papers). H. Mytrang collaborates with scholars based in United States, Italy and Germany. H. Mytrang's co-authors include Ming O. Li, Kristelle J. Capistrano, Chun Chou, Efstathios G. Stamatiades, Xian Zhang, Briana G. Nixon, Ke Xu, Min Peng, Shi Wei and Amy Shyu and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

H. Mytrang

14 papers receiving 956 citations

Hit Papers

Glycolysis fuels phosphoinositide 3-kinase signaling to b... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

H. Mytrang
Ang Cui United States
Chun Chou United States
H. Mytrang
Citations per year, relative to H. Mytrang H. Mytrang (= 1×) peers Kristelle J. Capistrano

Countries citing papers authored by H. Mytrang

Since Specialization
Citations

This map shows the geographic impact of H. Mytrang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Mytrang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Mytrang more than expected).

Fields of papers citing papers by H. Mytrang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Mytrang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Mytrang. The network helps show where H. Mytrang may publish in the future.

Co-authorship network of co-authors of H. Mytrang

This figure shows the co-authorship network connecting the top 25 collaborators of H. Mytrang. A scholar is included among the top collaborators of H. Mytrang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Mytrang. H. Mytrang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhang, Xian, Shun Li, H. Mytrang, et al.. (2023). Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature. 619(7970). 616–623. 77 indexed citations
2.
Nixon, Briana G., Chun Chou, Chirag Krishna, et al.. (2022). Cytotoxic granzyme C–expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Science Immunology. 7(70). eabi8642–eabi8642. 59 indexed citations
3.
Xu, Ke, Na Yin, Min Peng, et al.. (2021). Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 371(6527). 405–410. 252 indexed citations breakdown →
4.
Mytrang, H., Claire Stewart, & Joanna Harp. (2021). Cutaneous Manifestations of COVID-19 in the Inpatient Setting. Dermatologic Clinics. 39(4). 521–532. 7 indexed citations
5.
Xu, Ke, Na Yin, Min Peng, et al.. (2021). Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses. Immunity. 54(5). 976–987.e7. 82 indexed citations
6.
Mytrang, H., Dulce M. Barrios, Gregory S. Phillips, et al.. (2021). Dermatologic infections in cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology. 85(6). 1528–1536. 4 indexed citations
7.
Gjonbalaj, Mergim, James W. Keith, H. Mytrang, et al.. (2020). Antibiotic Degradation by Commensal Microbes Shields Pathogens. Infection and Immunity. 88(4). 24 indexed citations
8.
Li, Shun, Ming Liu, H. Mytrang, et al.. (2020). Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells. Nature. 587(7832). 121–125. 178 indexed citations
9.
Mytrang, H. & Shari R. Lipner. (2020). Contribution of gender on compensation of Veterans Affairs-affiliated dermatologists: A cross-sectional study. International Journal of Women’s Dermatology. 6(5). 414–418. 5 indexed citations
10.
Barrios, Dulce M., H. Mytrang, Gregory S. Phillips, et al.. (2020). Immune checkpoint inhibitors to treat cutaneous malignancies. Journal of the American Academy of Dermatology. 83(5). 1239–1253. 65 indexed citations
11.
Liu, Ming, Fengshen Kuo, Kristelle J. Capistrano, et al.. (2020). TGF-β suppresses type 2 immunity to cancer. Nature. 587(7832). 115–120. 153 indexed citations
12.
Mytrang, H., et al.. (2020). Trends in psoriasis treatment 2005 to 2018: Declining phototherapy utilization and concomitant increased use of biologics. Dermatologic Therapy. 33(6). e14276–e14276. 3 indexed citations
13.
Mytrang, H., Xinxin Wang, Xian Zhang, et al.. (2019). Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance. The Journal of Experimental Medicine. 217(1). 37 indexed citations
14.
Luo, Chong, Hatice U. Osmanbeyoglu, H. Mytrang, et al.. (2017). Ets transcription factor GABP controls T cell homeostasis and immunity. Nature Communications. 8(1). 1062–1062. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026